Health Topics — Sleep
Why You Wake at 3am
For the person who falls asleep without difficulty but wakes in the early hours and cannot get back — what cortisol, the HPA axis, and the endocannabinoid system have to do with it.
It is a specific and recognisable experience. You fall asleep without difficulty. Sometime between two and four in the morning — reliably, mysteriously — you are awake. Fully awake, or close enough. Your mind moves immediately to whatever it is that is weighing on you. Sometimes you can get back to sleep eventually. Often you cannot. You lie there until the alarm goes, and the day begins already depleted.
This pattern is not random and it is not simply a sleep problem. It has a specific biological explanation — and understanding it changes what makes sense to address.
Cortisol follows a daily rhythm. It is lowest in the hours of deep sleep — the first half of the night — and begins rising in the early morning hours, reaching its peak shortly after waking. This cortisol awakening response is one of the body's primary signals for transitioning from sleep to wakefulness. It is normal, useful, and ancient. The problem is that under chronic stress, this rhythm shifts — cortisol begins its rise earlier than it should, intruding into what should be the low-cortisol window of the early morning.
When cortisol rises at two or three in the morning instead of five or six, it activates the same arousal systems it would activate at a more appropriate hour — increasing alertness, raising heart rate, mobilising the brain toward waking. The body does not understand that it is the wrong time. It is following its programming. The programming has simply been reset by the chronic stress load that has been altering the HPA axis's timing.
This is why the thoughts that arrive at 3am tend to be the anxious, looping, worst-case variety. The prefrontal cortex — the part of the brain responsible for calm, contextualised reasoning — is not yet fully engaged at that hour. The amygdala — the threat-detection centre — is already activated by the cortisol signal. The result is the familiar experience of lying awake in the dark, thoughts moving in circles, problems feeling larger than they will in daylight.
Where the endocannabinoid system connects
The endocannabinoid system participates in the overnight regulation of the HPA axis. CB1 receptors in the hypothalamus are part of the feedback mechanism that moderates cortisol — signalling when enough has been produced and when the stress response should wind down. When endocannabinoid tone is depleted — as it is under chronic stress — this feedback is less effective. The cortisol rhythm becomes less well-regulated, more prone to the early-morning intrusion that produces the 3am waking pattern.
The locus coeruleus — the brain's primary norepinephrine hub — is also relevant here. It must be quiet for deep, restorative sleep to occur. Chronic stress sensitises the locus coeruleus, lowering its activation threshold. In the early morning hours, as cortisol begins its natural rise, a sensitised locus coeruleus fires more readily — contributing to the arousal that pulls a chronically stressed person out of sleep before they have had the restorative benefit of the second half of the night, which is disproportionately rich in REM sleep.
CBG's alpha-2 adrenoceptor mechanism is directly relevant to this pathway. The alpha-2 adrenoceptor regulates norepinephrine release from the locus coeruleus — activation of this receptor reduces norepinephrine output and lowers the arousal state it drives. This is the same mechanism implicated in CBG's stress-reducing effects in the Cuttler human trial. Whether that mechanism is relevant to overnight arousal and the 3am waking pattern specifically has not been studied. But the biology connects in a way that is coherent and worth knowing.
On the research and what it does and doesn't show
No study has examined CBG or CBD specifically for early-morning waking or cortisol timing disruption. The mechanisms described here are documented — the cortisol rhythm, the locus coeruleus's role in overnight arousal, the endocannabinoid system's involvement in HPA axis feedback. Their specific relevance to the 3am waking pattern is a coherent research hypothesis, not an established finding.
Persistent early-morning waking is worth discussing with a clinician. It can reflect sleep apnoea, mood disorders, or other conditions that have their own specific management. Understanding the cortisol biology is useful context — it is not a diagnosis.
What this means in practice
The 3am waking pattern is downstream of the chronic stress load that has shifted the cortisol rhythm. Addressing the sleep symptom in isolation — with sleep hygiene, with melatonin, with anything that acts on sleep directly — misses the upstream problem. If the cortisol timing is dysregulated by chronic stress, the most coherent intervention is one that addresses the stress biology that is driving the dysregulation.
This is why CBG preparations — which have their clearest human research evidence in the stress and anxiety domain — are more mechanistically relevant to this kind of sleep disruption than preparations researched specifically for sleep onset. The 3am waking is a stress problem that manifests at night, not a sleep problem that happens to involve stress.
People who use whole-plant CBG preparations consistently over time sometimes report that the 3am pattern improves before other sleep metrics do — which is consistent with the upstream cortisol hypothesis. This is anecdotal and cannot be used as evidence. It is the kind of signal that suggests the mechanism is in the right territory, and that the research question is worth asking properly.
Waking at 3am is not a mystery. It is the body's cortisol rhythm arriving early — driven upstream by a chronic stress load that has reset the HPA axis's timing. The endocannabinoid system is part of the regulatory architecture that moderates that rhythm. The research on CBG and the stress response is the most directly relevant evidence thread for this specific sleep experience — more so than the general sleep research, which addresses a different mechanism in a different population. That is the honest frame for thinking about it.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.